Patent · US Active

Dengue chimeric viruses

US7968102B2 · kind B2 · utility

4Cited by

1References

9Claims

0Family size

Assignee

Sanofi Pasteur SA · FR

Inventor

Marie-Jose Quentin-Millet · Villeurbanne, FR

Key dates

Filing date	Jan 4, 2007
Grant date	Jun 28, 2011
Priority date	—
Expiry date	Apr 6, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to Dengue chimeric viruses which are less prone to accumulate point mutations and genetic variations. In these Dengue chimeric viruses, the NS5 gene, which encodes polymerase, has been replaced by the corresponding NS5 sequence of a Yellow Fever virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.